Bipartisan Group of Senators Urge FDA Commissioner to Address Prescription Drug Costs
June 23, 2017
June 23, 2017
WASHINGTON, June 23 -- The office of Sen. Dianne Feinstein, D-Calif., issued the following news release:
Senator Dianne Feinstein (D-Calif.) joined a bipartisan group of Senate Judiciary Committee members led by Senator Amy Klobuchar (D-Minn.) to urge Food and Drug Administration (FDA) Commissioner Scott Gottlieb to address abuses in the regulatory process that delay competition and increase prescription drug costs. Commissioner Gottlieb recently stated that the FDA will take meas . . .
Senator Dianne Feinstein (D-Calif.) joined a bipartisan group of Senate Judiciary Committee members led by Senator Amy Klobuchar (D-Minn.) to urge Food and Drug Administration (FDA) Commissioner Scott Gottlieb to address abuses in the regulatory process that delay competition and increase prescription drug costs. Commissioner Gottlieb recently stated that the FDA will take meas . . .